Common Contracts
2 similar Exclusive License Agreement contracts by Vir Biotechnology, Inc.
EXCLUSIVE LICENSE AGREEMENT AMENDED AND RESTATEDExclusive License Agreement • August 7th, 2019 • Vir Biotechnology, Inc. • Biological products, (no disgnostic substances)
This Agreement, originally effective as of July 28, 2004, and as amended and restated December 16, 2011, is by and between the institute for Research in Biomedicine (“IRB”), with an address at Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland and Humabs Holding GmbH, with an address at c/o Risk-Consult AG, Poststrasse 22, 6300 Zug, Switzerland (“Humabs” or “Licensee”).
EXCLUSIVE LICENSE AGREEMENT BETWEEN THE INSTITUTE FOR RESEARCH IN BIOMEDICINE AND HUMABS BIOMED SA, A WHOLLY-OWNED SUBSIDIARY OF HUMABS, LLCExclusive License Agreement • August 7th, 2019 • Vir Biotechnology, Inc. • Biological products, (no disgnostic substances)
This Agreement, effective as of this December 16, 2011, is by and between the Institute for Research in Biomedicine (“IRB”), with an address at Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland and Humabs Biomed SA, with an address at via Murate 5a, 6500 Bellinzona (“Humabs” or “Licensee”) which is a wholly-owned subsidiary of Humabs Holding GmbH (“Humabs Parent”), a Swiss limited liability company with an address at c/o Risk-Consult AG, Poststrasse 22, 6300 Zug, Switzerland.
